Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InnoCare OptoelectronicsTPE:6861 -0.26%74 EV-to-EBITDA is 17.87 as of Aug. 31, 2026, which is 57% above its 10-year median of 11.40. GuruFocus rates TPE:6861 with a GF Score™ of 74/100 and a GF Value™ of NT$101.46 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 520 Medical Devices & Instruments companies, InnoCare Optoelectronics ranks worse than 60% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, InnoCare Optoelectronics's enterprise value is NT$7,290 Mil.
InnoCare Optoelectronics's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$408 Mil. Therefore, InnoCare Optoelectronics's EV-to-EBITDA for today is 17.87.
The historical rank and industry rank for InnoCare Optoelectronics's EV-to-EBITDA or its related term are showing as below:
TPE:6861'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.18 Med: 11.4 Max: 55.64
Current: 17.87
During the past 8 years, the highest EV-to-EBITDA of InnoCare Optoelectronics was 55.64. The lowest was 4.18. And the median was 11.40.
TPE:6861's EV-to-EBITDA is ranked worse than 60% of 520
companies
in the Medical Devices & Instruments industry
Industry Median: 14.68
vs TPE:6861: 17.87
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
InnoCare Optoelectronics's PE Ratio (TTM) for today is calculated as:
InnoCare Optoelectronics's share price for today is NT$193.50.
InnoCare Optoelectronics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$6.400.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6861 vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, InnoCare Optoelectronics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InnoCare Optoelectronics EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InnoCare Optoelectronics's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where InnoCare Optoelectronics's EV-to-EBITDA falls into.
InnoCare Optoelectronics's current Enterprise Value is NT$7,290 Mil.
InnoCare Optoelectronics's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$408 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnoCare Optoelectronics (TPE:6861) has a EV-to-EBITDA of 17.87 as of Aug. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on InnoCare Optoelectronics. This is 57% above median its historical median of 11.40. Over the past decade, InnoCare Optoelectronics' EV-to-EBITDA has ranged from 4.18 to 55.64. According to the industry distribution chart, InnoCare Optoelectronics ranks #312 out of 520 companies in the Medical Devices & Instruments industry, placing it in the top 60%.
Is InnoCare Optoelectronics' EV-to-EBITDA too high?
InnoCare Optoelectronics' current EV-to-EBITDA of 17.87 is 57% above median its 10-year median of 11.40. Over the past 10 years, this metric has ranged from a low of 4.18 to a high of 55.64. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.68. InnoCare Optoelectronics' value of 17.87 is 21.7% above this industry median. Based on the distribution chart, InnoCare Optoelectronics ranks #312 out of 520 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, InnoCare Optoelectronics has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnoCare Optoelectronics' EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, InnoCare Optoelectronics ranks #312 out of 520 companies for EV-to-EBITDA. This places InnoCare Optoelectronics in the lower half of its industry. The industry median EV-to-EBITDA is 14.68. InnoCare Optoelectronics' value of 17.87 is 21.7% above this benchmark. Historically, InnoCare Optoelectronics' own EV-to-EBITDA has ranged from 4.18 to 55.64 over the past decade. While the company's 10-year median is 11.40 vs. the industry median of 14.68, InnoCare Optoelectronics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.68, based on 520 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InnoCare Optoelectronics's current EV-to-EBITDA of 17.87 is 21.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on InnoCare Optoelectronics. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InnoCare Optoelectronics's current EV-to-EBITDA is 17.87, which is 57% above median its own 10-year median of 11.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnoCare Optoelectronics stock overvalued right now?
Based on GuruFocus' analysis, InnoCare Optoelectronics (TPE:6861) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$101.46, compared to a current price of NT$193.50 — trading 90.7% above its estimated fair value. The current EV-to-EBITDA is 17.87, which is 57% above median its 10-year median of 11.40 and 21.7% above the Medical Devices & Instruments industry median of 14.68. InnoCare Optoelectronics' overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For InnoCare Optoelectronics (TPE:6861), the current EV-to-EBITDA is 17.87 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InnoCare Optoelectronics (TPE:6861) Overvalued in 2026?
Based on GuruFocus' analysis, InnoCare Optoelectronics stock appears to be overvalued.
The current stock price of NT$193.50 is trading 90.7% above its estimated GF Value™ of NT$101.46.
GuruFocus considers InnoCare Optoelectronics to be Significantly Overvalued.
Key valuation signals for TPE:6861:
EV-to-EBITDA: 17.87 (57% above median its 10-year median of 11.40)
GF Value™: NT$101.46 vs. price of NT$193.50 (90.7% above fair value)
Industry Position: 21.7% above the Medical Devices & Instruments median (#312 of 520)
No single metric tells the full story. See the TPE:6861 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InnoCare Optoelectronics Corp is mainly engaged in the manufacturing and sale of optical instruments and medical equipment. Its products include X-Ray flat panel detector devices, X-Ray flat panel detector modules, and others.
74GF Score
Get the complete analysis for TPE:6861
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6861 has been successfully added to your 
